- SEK965.73m
- SEK836.63m
- SEK441.90m
Brief: C Rad Q1 Operating Profit Falls To SEK 0.2 Mln
Brief: C-Rad Receives Order On Its Sgrt Solution
Brief: C-Rad Gets Order For Catalyst+ HD And Sentinel 4DCT From Regensburg University Hospital
Brief: C-Rad's Gets Purchase Order Worth SEK 20 Mln In Belgium
Brief: C Rad Q3 Operating Income Rises To SEK 8.8 Mln
Brief: C-Rad And Accuray Sign Agreement To Enhance Radixact System Breast Cancer Treatment Capabilities
Brief: Accuray Inc and C-Rad Sign Agreement To Enhance Radixact System Breast Cancer Treatment Capabilities
Brief: C Rad Q2 Operating Profit Rises To SEK 6.0 Mln
Brief: C-RAD: Former Employee Appeals Verdict From Stockholm Patent And Market Court
Brief: C Rad Announces Court Resolution On Former Employee's Claims
Brief: C-Rad Establishes Office In Delhi
Brief: C Rad Q1 Operating Profit Rises To SEK 6.2 Mln
Brief: C-RAD: Patent And Market Court Of Appeal Confirms Co's Entitlement To Beamocular's Invention
Brief: C-Rad Signs Distribution Agreement With South Korean Company
Brief: C Rad Q4 Operating Result Swings To Profit SEK 9.8 Mln
Brief: C-Rad Gets Order Worth SEK 15 Mln
Brief: C Rad Gets Order From Ion Beam Applications
Brief: C Rad AB - Q3 Order Intake Increased 15% To SEK 80.5 mln
Brief: C-RAD: SIGRT Solution Selected By Australian Customers